2026-01-16 - Analysis Report
**Company Overview**
Procter & Gamble Co, a well-established consumer goods company.

**Return Rate Comparison**
* Review Stock (PG): 22.40% cumulative return
* Comparison Stock (VOO S&P 500): 92.89% cumulative return
* Divergence from the comparison stock: -70.50 (on the last data day)

**Alpha, Beta Analysis**
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 4.0% | 10.7% | 1.0% | 0.5 | 212.9B |
| 2017-2019  | 23.0% | 10.7% | 5.0% | 0.5 | 289.3B |
| 2018-2020  | 26.0% | 17.9% | 5.0% | 0.7 | 322.3B |
| 2019-2021  | 39.0% | 17.9% | -5.0% | 0.7 | 378.9B |
| 2020-2022  | 11.0% | 17.9% | 13.0% | 0.6 | 351.1B |
| 2021-2023  | 24.0% | 15.9% | 23.0% | 0.4 | 339.4B |
| 2022-2024  | 7.0% | 15.9% | -12.0% | 0.4 | 388.3B |
| 2023-2025  | -19.0% | 21.6% | -81.0% | 0.2 | 331.9B |

**Stock Price Fluctuations**
* Close: $146.35
* Last-market: $144.86
* Change: -1.02
* Moving averages:
	+ 5-day SMA: $143.49
	+ 20-day SMA: $143.38
	+ 60-day SMA: $145.96

**Indicators and Analysis**
* RSI: 59.57
* PPO: 0.34
* Expected Return (%): 1.30%
* Recent relative divergence change: +6.30 (improving)
* Recent 7-day Rank change: -62 (rank down)
* Recent 7-day Dynamic Expected Return change: -12.50 (worsening)
* Market Risk Indicator (MRI): 0.70 (Medium Investment)
* Recent News & Significant Events:
	+ Multiple articles about the company's dividend stock, including a Motley Fool article recommending it.
	+ News about the company's CEO possibly receiving a large wealth boost from stock incentives.
	+ Other news articles mentioned in the provided list.

**Analyst Opinions**
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.00 (~Buy)
- Opinions: 22
- Target Price (avg/high/low): $165.50 / $186.00 / $148.00

**Recent Earnings Analysis**
| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-24 | 2 | $22.39 B |
| 2025-04-24 | 1.58 | $19.78 B |
| 2025-01-22 | 1.94 | $21.88 B |
| 2024-10-18 | 1.65 | $21.74 B |

**Revenue and Profitability**
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $22.39B | 51.37% |
| 2025-06-30 | $20.89B | 49.11% |
| 2025-03-31 | $19.78B | 50.98% |
| 2024-12-31 | $21.88B | 52.39% |
| 2024-09-30 | $21.74B | 52.06% |

**Capital and Profitability**
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $53.27B | 8.92% |
| 2025-06-30 | $52.01B | 6.95% |
| 2025-03-31 | $52.27B | 7.21% |
| 2024-12-31 | $51.17B | 9.05% |
| 2024-09-30 | $51.84B | 7.64% |

**Comprehensive Analysis**
The company has shown a significant divergence from the comparison stock (VOO S&P 500) with a -70.50 difference on the last data day. The Alpha, Beta analysis shows varying performance across different time periods, with some periods showing positive alpha and others showing negative alpha. The RSI is 59.57, and the PPO is 0.34, indicating a balanced market. The Expected Return is 1.30%. The recent relative divergence change is +6.30 (improving), while the 7-day Rank change is -62 (rank down). The Market Risk Indicator (MRI) is 0.70 (Medium Investment). The recent news and significant events suggest a positive outlook for the company's dividend stock and possible wealth boost for the CEO. The analyst opinions recommend a 'Buy' with a target price of $165.50. The recent earnings analysis shows a mix of revenue and EPS changes. The revenue and profitability analysis shows varying profit margins across different quarters, while the capital and profitability analysis shows a mix of equity and ROE changes.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.